Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy of the RTS,S/AS01 malaria vaccine in children against episodes of malaria caused by Plasmodium falciparum. Results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mosquirix (RTS,S/AS01E)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2018-07-03